Latest trials Stories
JERUSALEM, May 11, 2011 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc.
Systematic reviews that attempt to assess the risk of harms (adverse effects) associated with specific therapies should consider a broad range of study designs, including both systematic reviews and observational studies.
There are now 75 clinical trials and 11 systematic reviews of trials published every day, with no signs this pace is slowing.
Comprehensive study of outcome reporting taps ClinicalTrials.gov BOSTON, Aug.
A Johns Hopkins review of nearly 150 randomized controlled trials on children â€” all published in well-regarded medical journals â€” reveals that 40 to 60 percent of the studies either failed to take steps to minimize risk for bias or to at least properly describe those measures.
Research: The quality of reports of randomized trials in 2000 and 2006: Comparative study of articles indexed in PubMed
Can we trust the results of research done on children?
A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases.
Published clinical trials impact health care providers, consumers and policy-makers. New research shows many Chinese trials published as credible may not be fully accurate.
JERUSALEM, June 10 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced that Oramed was chosen to present at the 8th National Life Science & Technology Week ILSI-BIOMED Conference, Israel 2009.